Synapse

← Adrian L. Harris

Papers by Adrian L. Harris

Page 5 · newest first

  1. Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survivalBiochemical Journal · 2012
  2. Gene Expression Analysis in Human Breast Cancer Associated Blood VesselsPLoS ONE · 2012
  3. Endothelial cell metabolism and implications for cancer therapyBritish Journal of Cancer · 2012
  4. Targeting the ATF4 pathway in cancer therapyExpert Opinion on Therapeutic Targets · 2012
  5. Regulation of intracellular pH in cancer cell lines under normoxia and hypoxiaJournal of Cellular Physiology · 2012
  6. Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trialsBritish Journal of Cancer · 2012
  7. CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCCCarcinogenesis · 2012
  8. Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced CancerClinical Cancer Research · 2012
  9. Importance of Intracellular pH in Determining the Uptake and Efficacy of the Weakly Basic Chemotherapeutic Drug, DoxorubicinPLoS ONE · 2012
  10. Targeting Carbonic Anhydrases with Fluorescent BODIPY‐Labelled SulfonamidesEuropean Journal of Inorganic Chemistry · 2012
  11. Small-molecule inhibitors of the HIF pathway and synthetic lethal interactionsExpert Opinion on Therapeutic Targets · 2012
  12. Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF TherapyClinical Cancer Research · 2012
  13. ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancerBreast Cancer Research · 2012
  14. Expression of vascular Notch ligands Delta‐like 4 and Jagged‐1 in glioblastomaHistopathology · 2012
  15. Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progressionJournal of Clinical Investigation · 2012
  16. Igf2 ligand dependency of Pten+/− developmental and tumour phenotypes in the mouseOncogene · 2011
  17. New pathways and mechanisms regulating and responding to Delta-like ligand 4–Notch signalling in tumour angiogenesisBiochemical Society Transactions · 2011
  18. ATF4 (activating transcription factor 4 (tax-responsive enhancer element B67))Atlas of Genetics and Cytogenetics in Oncology and Haematology · 2011
  19. Delta-Like Ligand 4–Notch Blockade and Tumor Radiation ResponseJNCI Journal of the National Cancer Institute · 2011
  20. International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010)JNCI Monographs · 2011
  21. Molecular Oncology and the Neoadjuvant Setting: the Perfect Blend for Treatment Personalization and Clinical Trial DesignJNCI Monographs · 2011
  22. Assessing Early Therapeutic Response to Bevacizumab in Primary Breast Cancer Using Magnetic Resonance Imaging and Gene Expression ProfilesJNCI Monographs · 2011
  23. DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In VivoCancer Research · 2011
  24. microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast CancerCancer Research · 2011
  25. Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast CancerPLoS ONE · 2011
  26. p21-activated kinase 1: PAK'ed with potentialOncotarget · 2011
  27. Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK787/ZK 222584 (Vatalanib) Antiangiogenic TherapyClinical Cancer Research · 2011
  28. Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomasBMC Cancer · 2011
  29. Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancerBritish Journal of Cancer · 2011
  30. Aberrant succination of proteins in fumarate hydratase‐deficient mice and HLRCC patients is a robust biomarker of mutation statusThe Journal of Pathology · 2011
  31. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking AnalysisNanomedicine Nanotechnology Biology and Medicine · 2011
  32. Expression of hypoxia‐associated proteins in sporadic medullary thyroid cancer is associated with desmoplastic stroma reaction and lymph node metastasis and may indicate somatic mutations in the VHL geneThe Journal of Pathology · 2011
  33. Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cellsProceedings of the National Academy of Sciences · 2011
  34. Notch Regulation of Tumor AngiogenesisFuture Oncology · 2011
  35. Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancersBreast Cancer Research · 2011
  36. Notch3 signalling promotes tumour growth in colorectal cancerThe Journal of Pathology · 2011
  37. The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosisBritish Journal of Cancer · 2011
  38. Nuclear Localization of Factor Inhibitor Hypoxia-Inducible Factor in Prostate Cancer Is Associated With Poor PrognosisThe Journal of Urology · 2011
  39. The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifenBreast Cancer Research · 2011
  40. Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast CancerClinical Cancer Research · 2011
  41. Gene expression and hypoxia in breast cancerGenome Medicine · 2011
  42. HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast CancerPLoS Biology · 2010
  43. Angiogenesis - still a worthwhile target for breast cancer therapy?Breast Cancer Research · 2010
  44. Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomasJournal of Clinical Pathology · 2010
  45. A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping dataGenome biology · 2010
  46. Human endothelial stem/progenitor cells, angiogenic factors and vascular repairJournal of The Royal Society Interface · 2010
  47. Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxiaBritish Journal of Cancer · 2010
  48. Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UKENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2010
  49. The Histone Demethylase JMJD2B Is Regulated by Estrogen Receptor α and Hypoxia, and Is a Key Mediator of Estrogen Induced GrowthCancer Research · 2010
  50. 6-Thioguanine Selectively Kills BRCA2-Defective Tumors and Overcomes PARP Inhibitor ResistanceCancer Research · 2010